壮骨强筋法治疗骨质疏松症的疗效分析(1)
 |
| 第1页 |
参见附件(1605KB，2页)。
[摘要] 目的：观察壮骨强筋法治疗骨质疏松症的效果。方法：将60例骨质疏松症患者随机分为治疗组和对照组，每组各30例。治疗组口服自拟壮骨强筋方，对照组口服阿法骨化醇软胶囊，观察比较两组治疗后的临床总体疗效及骨密度变化情况。结果：治疗组总有效率为90.0%，对照组为73.3%。在临床总体疗效和骨密度测定方面，治疗组较对照组明显改善，差异有统计学意义(P<0.05)。结论：自拟壮骨强筋方治疗骨质疏松症疗效确切。
[关键词] 壮骨强筋法；骨质疏松症；疗效；分析
[中图分类号] R2 [文献标识码] B [文章编号] 1674-4721(2011)12(b)-108-02
Efficacy analysis of strengthening bones and tendons in the treatment of osteoporosis
LI Min1, ZHANG Qicheng2
1.Department of TCM Orthopaedics, Guilin Hospital of Chaoyang District in Changchun City, Jilin Province, Changchun 130021, China; 2. Department of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Jilin Province, Changchun 130041, China
[Abstract] Objective: To observe the efficacy of strengthening bones and tendons in the treatment of osteoporosis. Methods: Sixty patients with osteoporosis were randomly divided into treatment group and control group, with 30 cases in each group. The treatment group was given self-made Zhuangguqiangjin decoction, the control group was given Alfacalcidol soft Capsules. The total clinical efficacy and changes of bone mineral density after treatment between the two groups were observed and compared. Results: The total effective rate was 90.0% in the treatment group and 73.3% in the control group. The total clinical efficacy and the measurement of bone mineral density in the treatment group were much better than the control group, the differences were significant (P<0.05). Conclusion: The clinical efficacy of self-made Zhuangguqiangjin decoction in the treatment of osteoporosis is exact.
[Key words] Strengthening bones and tendons methods; Osteoporosis; Efficacy; Analysis
骨质疏松症(osteoporosis，OP)为骨科常见病之一，其特征是骨矿量减少和骨组织微细结构破坏，导致骨的脆性增加，易发生骨折的一种系统性、全身性骨骼疾病。其临床症状主要是不同程度、不同部位的骨骼及关节疼痛，早期多表现为肢体乏力、酸软，周身游走性疼痛，肌肉抽搐，部分患者出现胃肠功能紊乱，抵抗力低下，发病率较高。中医药治疗本病有着独特的优势，疗效显著。依据多年来的临床经验总结，笔者将2009年8月～2010年8月我院收治的骨质疏松症患者60例，采用自拟壮骨强筋方治疗，取得了显著疗效，现将结果报道如下：
1 资料与方法
1.1 一般资料
将2009年8月～2010年8月我院确诊为骨质疏松症肝肾不足的患者60例随机分为治疗组30例，对照组30例，其中，男24例，女36例，年龄47～75岁，平均61岁。治疗组男11例，女19例；年龄49～75岁。对照组男13例，女17例；年龄47～73岁。两组性别、年龄等一般资料比较，差异无统计意义(P>0.05)，具有可比性。
1.2 纳入标准
参照《中药新药临床研究的指导原则》骨质疏松症的诊断标准制定[1]：①腰脊疼痛明显，逐渐加重，脊椎常有后凸畸形；②X线表现骨质普遍稀疏 ......
您现在查看是摘要介绍页，详见PDF附件(1605KB，2页)。